ExpreS2ion Biotech Holding AB Strategic Asset Allocation Index
ExpreS2ion Biotech Holding AB strategic asset allocation index. ExpreS2ion Biotech Holding AB (EXPRS2) has a Strategic Asset Allocation Index of 1.3% as of December 2025. Strategic assets (PP&E of Skr465.00K plus long-term investments of Skr-) total Skr465.00K, measured against net assets of Skr35.69 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ExpreS2ion Biotech Holding AB balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of ExpreS2ion Biotech Holding AB (2016–2025)
Strategic asset allocation index of ExpreS2ion Biotech Holding AB from 2016 to 2025. This chart shows how ExpreS2ion Biotech Holding AB's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2025. As of December 2025, the index stands at 1.3%, representing strategic assets of Skr465.00K against net assets of Skr35.69 Million SEK. Check EXPRS2 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
ExpreS2ion Biotech Holding AB Strategic Asset Allocation Index by Year (2016–2025)
ExpreS2ion Biotech Holding AB strategic asset allocation index by year from 2016 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for ExpreS2ion Biotech Holding AB from 2016 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ExpreS2ion Biotech Holding AB stock valuation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.3% | Skr465.00K | Skr465.00K | Skr- | Skr35.69 Million | ▼ -1.1 pp |
| 2024 | 2.4% | Skr1.53 Million | Skr1.53 Million | Skr- | Skr64.42 Million | ▼ -0.3 pp |
| 2023 | 2.7% | Skr1.77 Million | Skr1.77 Million | Skr- | Skr65.36 Million | ▲ +1.8 pp |
| 2022 | 0.9% | Skr910.00K | Skr910.00K | Skr- | Skr103.33 Million | ▲ +0.0 pp |
| 2021 | 0.9% | Skr1.21 Million | Skr1.21 Million | Skr- | Skr140.35 Million | ▼ -0.5 pp |
| 2020 | 1.4% | Skr1.29 Million | Skr1.29 Million | Skr- | Skr94.55 Million | ▼ -10.6 pp |
| 2018 | 12.0% | Skr993.00K | Skr993.00K | Skr- | Skr8.30 Million | ▲ +2.6 pp |
| 2017 | 9.4% | Skr632.00K | Skr632.00K | Skr- | Skr6.74 Million | ▲ +4.1 pp |
| 2016 | 5.3% | Skr679.00K | Skr679.00K | Skr- | Skr12.88 Million | — |